Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Org 32489

Known as: Org-32489 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1996
1996
To investigate whether the progesterone antagonist RU486 has a direct effect on ovarian function, it was administered to immature… Expand
Is this relevant?
Highly Cited
1995
Highly Cited
1995
During fetal development, anti-müllerian hormone (AMH) is produced only by Sertoli cells, but postnatally, granulosa cells also… Expand
Is this relevant?
Highly Cited
1995
Highly Cited
1995
In this study the in-vitro biopotency and glycoform distribution of human recombinant follicle stimulating hormone (FSH, Org… Expand
Is this relevant?
Highly Cited
1995
Highly Cited
1995
The objective of this study was to compare the efficacy and safety of a recombinant follicle stimulating hormone (FSH… Expand
Is this relevant?
Highly Cited
1994
Highly Cited
1994
In total, 50 couples participated in a pilot study evaluating the efficacy of various regimens of gonadotrophin-releasing hormone… Expand
Is this relevant?
1994
1994
To examine the role of FSH and LH in follicular growth and atresia, immature hypophysectomized (hypox) rats were treated twice… Expand
Is this relevant?
1993
1993
This case report describes the first established pregnancy and birth after ovarian stimulation with Org 32489, pure recombinant… Expand
Is this relevant?